BENRALIZUMAB

BENRALIZUMAB was reported 20994 times

BENRALIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EOSINOPHILIC OTITIS MEDIA 11 0.3143
1 CHRONIC EOSINOPHILIC RHINOSINUSITIS 9 0.2647
2 CAPUT SUCCEDANEUM 7 0.2414
3 INFECTIVE EXACERBATION OF ASTHMA 8 0.1538
4 EOSINOPHIL COUNT 10 0.0862
5 EOSINOPHIL COUNT ABNORMAL 62 0.0830
6 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 169 0.0828
7 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 12 0.0670
8 BACTERIAL DISEASE CARRIER 39 0.0535
9 BRAIN MALFORMATION 19 0.0532
10 BRONCHIAL WALL THICKENING 36 0.0501
11 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
12 BRONCHIAL SECRETION RETENTION 46 0.0361
13 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 5 0.0338
14 HYPEREOSINOPHILIC SYNDROME 18 0.0333
15 EOSINOPHIL COUNT INCREASED 260 0.0312
16 BRONCHIAL OBSTRUCTION 41 0.0292
17 ASTHMA 3144 0.0278
18 ASTHMATIC CRISIS 87 0.0238
19 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 22 0.0237
20 EOSINOPHILIC PNEUMONIA CHRONIC 7 0.0236
21 TRACHEOMALACIA 9 0.0228
22 SARS-COV-2 TEST NEGATIVE 15 0.0222
23 NASAL POLYPS 104 0.0211
24 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
25 PEAK EXPIRATORY FLOW RATE DECREASED 9 0.0205
26 EOSINOPHIL COUNT DECREASED 47 0.0197
27 BLOOD IMMUNOGLOBULIN E INCREASED 43 0.0177
28 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 19 0.0176
29 CEREBRAL VENTRICLE DILATATION 19 0.0165
30 SINUS POLYP 9 0.0156
31 SINONASAL OBSTRUCTION 6 0.0149
32 CARDITIS 6 0.0143
33 FULL BLOOD COUNT ABNORMAL 147 0.0139
34 SYMPTOM RECURRENCE 82 0.0137
35 SPIROMETRY ABNORMAL 8 0.0134
36 WHEEZING 791 0.0133
37 OBSTRUCTIVE AIRWAYS DISORDER 140 0.0126
38 INCREASED BRONCHIAL SECRETION 32 0.0125
39 ACTIVITIES OF DAILY LIVING DECREASED 8 0.0125
40 OBSTRUCTIVE SLEEP APNOEA SYNDROME 17 0.0117
41 FORCED EXPIRATORY VOLUME DECREASED 32 0.0113
42 TYPE III IMMUNE COMPLEX MEDIATED REACTION 6 0.0107
43 POST-ACUTE COVID-19 SYNDROME 13 0.0105
44 PNEUMONIA PSEUDOMONAL 16 0.0104
45 DEVICE LEAKAGE 447 0.0103
46 BLASTOMYCOSIS 5 0.0103
47 INFECTION PARASITIC 8 0.0102
48 CYTOKINE STORM 7 0.0102
49 PULMONARY FUNCTION TEST DECREASED 44 0.0100
50 SPINAL CORD COMPRESSION 39 0.0100
51 PULMONARY FUNCTION TEST ABNORMAL 15 0.0096
52 OLIGOHYDRAMNIOS 32 0.0096
53 CARBOHYDRATE ANTIGEN 19-9 INCREASED 5 0.0095
54 LOWER RESPIRATORY TRACT INFECTION 430 0.0094
55 SPUTUM DISCOLOURED 89 0.0094
56 INCORRECT DOSE ADMINISTERED BY DEVICE 240 0.0091
57 MULTIPLE ALLERGIES 71 0.0090
58 MYCOPLASMA INFECTION 7 0.0090
59 INJECTION SITE INDENTATION 19 0.0088
60 TREATMENT DELAYED 15 0.0087
61 NOCTURNAL DYSPNOEA 11 0.0086
62 PNEUMOCYSTIS JIROVECII INFECTION 10 0.0084
63 INSURANCE ISSUE 128 0.0084
64 EOSINOPHILIC PNEUMONIA 26 0.0082
65 EOSINOPHILIC MYOCARDITIS 6 0.0082
66 BRONCHIECTASIS 55 0.0082
67 BODY MASS INDEX INCREASED 11 0.0081
68 INCORRECT DOSE ADMINISTERED BY PRODUCT 13 0.0081
69 LOCAL REACTION 6 0.0081
70 RHINOVIRUS INFECTION 31 0.0080
71 SENSE OF OPPRESSION 9 0.0076
72 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 129 0.0076
73 RALES 44 0.0076
74 RHINITIS 61 0.0076
75 SERUM SICKNESS 21 0.0075
76 TOTAL LUNG CAPACITY DECREASED 12 0.0075
77 ALLERGY TO ANIMAL 8 0.0075
78 HAEMATOLOGICAL INFECTION 18 0.0074
79 QUALITY OF LIFE DECREASED 98 0.0073
80 RHONCHI 10 0.0072
81 DRUG DELIVERY SYSTEM ISSUE 14 0.0071
82 SHOULDER FRACTURE 11 0.0067
83 PNEUMONIA INFLUENZAL 8 0.0067
84 RESPIRATORY TRACT IRRITATION 7 0.0067
85 EXERCISE TOLERANCE DECREASED 38 0.0066
86 DECREASED ACTIVITY 71 0.0066
87 SECRETION DISCHARGE 82 0.0065
88 RHINITIS ALLERGIC 29 0.0065
89 CRITICAL ILLNESS 5 0.0064
90 CROUP INFECTIOUS 5 0.0063
91 HYPERSENSITIVITY PNEUMONITIS 7 0.0061
92 PULMONARY GRANULOMA 7 0.0061
93 DEVICE USE ISSUE 107 0.0061
94 ADMINISTRATION SITE PAIN 7 0.0061
95 PSEUDOMONAS INFECTION 52 0.0061
96 HYPERVENTILATION 35 0.0060
97 PRODUCT DISTRIBUTION ISSUE 56 0.0060
98 MYCOBACTERIUM AVIUM COMPLEX INFECTION 16 0.0060
99 DEVICE DISPENSING ERROR 7 0.0059
100 SINUS DISORDER 115 0.0058
101 BLOOD IMMUNOGLOBULIN G INCREASED 7 0.0058
102 EOSINOPHILIA 100 0.0057
103 MAST CELL ACTIVATION SYNDROME 8 0.0057
104 RESPIRATION ABNORMAL 39 0.0057
105 NASAL DISORDER 15 0.0056
106 DEVICE DELIVERY SYSTEM ISSUE 150 0.0055
107 PULMONARY CONGESTION 72 0.0055
108 OROPHARYNGEAL DISCOMFORT 49 0.0054
109 ATYPICAL PNEUMONIA 16 0.0053
110 LUNG OPACITY 14 0.0053
111 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46 0.0053
112 ATRIAL FLUTTER 42 0.0053
113 PHARYNGEAL SWELLING 51 0.0052
114 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 241 0.0052
115 PRODUCTIVE COUGH 246 0.0051
116 NEEDLE ISSUE 150 0.0051
117 BRONCHOSPASM 73 0.0051
118 RESPIRATORY TRACT CONGESTION 81 0.0051
119 CHRONIC SINUSITIS 19 0.0051
120 ACQUIRED HAEMOPHILIA 5 0.0050
121 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 259 0.0050
122 ECTOPIC PREGNANCY 15 0.0049
123 IMPAIRED QUALITY OF LIFE 70 0.0049
124 INJECTION RELATED REACTION 8 0.0048
125 BREAST NEOPLASM 5 0.0048
126 WRIST FRACTURE 58 0.0048
127 MIDDLE INSOMNIA 90 0.0048
128 FRACTURED COCCYX 6 0.0047
129 PNEUMONIA PNEUMOCOCCAL 7 0.0047
130 HYPOSMIA 7 0.0047
131 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 218 0.0045
132 INTENTIONAL DEVICE MISUSE 20 0.0045
133 BRONCHITIS CHRONIC 11 0.0045
134 FOETAL GROWTH RESTRICTION 26 0.0043
135 OXYGEN SATURATION ABNORMAL 12 0.0042
136 RESPIRATORY SYMPTOM 12 0.0042
137 CHEST DISCOMFORT 431 0.0042
138 LUNG DISORDER 204 0.0042
139 PULMONARY MASS 62 0.0042
140 SPUTUM INCREASED 9 0.0042
141 CHRONIC RESPIRATORY FAILURE 5 0.0041
142 LOWER RESPIRATORY TRACT CONGESTION 7 0.0041
143 INJECTION SITE DISCHARGE 22 0.0041
144 PNEUMONIA FUNGAL 16 0.0041
145 VOCAL CORD DISORDER 8 0.0041
146 DEVICE DEFECTIVE 70 0.0040
147 SEASONAL ALLERGY 57 0.0040
148 ALLERGY TO CHEMICALS 5 0.0040
149 INFUSION SITE DISCHARGE 7 0.0040
150 CYSTIC FIBROSIS 22 0.0040
151 COUGH 1111 0.0040
152 VASCULITIS 46 0.0039
153 RUBBER SENSITIVITY 6 0.0039
154 NASAL CONGESTION 230 0.0039
155 MEAN CELL VOLUME INCREASED 10 0.0039
156 NEURITIS 6 0.0039
157 BODY TEMPERATURE ABNORMAL 7 0.0038
158 ILLNESS 390 0.0038
159 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 268 0.0038
160 PNEUMONIA 1218 0.0038
161 DYSPNOEA 2109 0.0037
162 DRUG EFFECT LESS THAN EXPECTED 55 0.0037
163 ADRENAL INSUFFICIENCY 45 0.0037
164 PHARYNGITIS 46 0.0037
165 JAUNDICE NEONATAL 7 0.0037
166 CARBON DIOXIDE INCREASED 5 0.0037
167 PRODUCT DOSE OMISSION ISSUE 1078 0.0037
168 SNEEZING 82 0.0037
169 OXYGEN THERAPY 6 0.0036
170 EOSINOPHILIC OESOPHAGITIS 10 0.0036
171 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
172 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
173 RESPIRATORY TRACT INFECTION 92 0.0035
174 EXPOSURE TO SARS-COV-2 6 0.0035
175 ASPERGILLUS INFECTION 23 0.0035
176 POLYMYALGIA RHEUMATICA 11 0.0035
177 DYSPNOEA EXERTIONAL 130 0.0034
178 SNORING 13 0.0034
179 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 619 0.0034
180 PULMONARY PAIN 10 0.0034
181 UPPER-AIRWAY COUGH SYNDROME 28 0.0034
182 CHEST INJURY 7 0.0034
183 CONJUNCTIVITIS ALLERGIC 5 0.0034
184 EMPHYSEMA 34 0.0034
185 NEAR DEATH EXPERIENCE 11 0.0033
186 DYSPHONIA 192 0.0033
187 ESSENTIAL HYPERTENSION 6 0.0033
188 ANOSMIA 47 0.0032
189 INFUSION SITE BRUISING 7 0.0032
190 OXYGEN SATURATION DECREASED 179 0.0032
191 UPPER LIMB FRACTURE 62 0.0031
192 INJECTION SITE INJURY 17 0.0031
193 ANAPHYLACTIC REACTION 169 0.0031
194 POLYP 20 0.0031
195 PNEUMONIA BACTERIAL 28 0.0030
196 ORAL PRURITUS 7 0.0030
197 THERAPEUTIC RESPONSE SHORTENED 101 0.0030
198 SUSPECTED COVID-19 10 0.0030
199 INABILITY TO AFFORD MEDICATION 30 0.0030
200 EMPYEMA 6 0.0030
201 ARTERIOSPASM CORONARY 12 0.0030
202 MIGRAINE WITH AURA 8 0.0029
203 PREMATURE RUPTURE OF MEMBRANES 7 0.0029
204 ACUTE SINUSITIS 5 0.0029
205 SLOW SPEECH 7 0.0029
206 AUTOIMMUNE DISORDER 28 0.0029
207 PNEUMOTHORAX 45 0.0028
208 CARTILAGE INJURY 7 0.0028
209 VIRAL INFECTION 94 0.0028
210 APHONIA 39 0.0028
211 OROPHARYNGEAL PAIN 256 0.0028
212 OBSTRUCTION 11 0.0028
213 THORACIC VERTEBRAL FRACTURE 8 0.0027
214 THROAT TIGHTNESS 73 0.0027
215 COVID-19 472 0.0027
216 DEMENTIA 75 0.0027
217 CONJUNCTIVITIS 49 0.0026
218 BLOOD COUNT ABNORMAL 40 0.0026
219 ARTERIAL DISORDER 5 0.0026
220 ARTHRITIS INFECTIVE 12 0.0026
221 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
222 DEVICE MALFUNCTION 181 0.0026
223 SINUS PAIN 6 0.0026
224 PATELLA FRACTURE 6 0.0026
225 PARAESTHESIA ORAL 37 0.0026
226 URTICARIA 429 0.0026
227 INFLUENZA 285 0.0026
228 INFUSION SITE SWELLING 16 0.0025
229 INFUSION SITE PRURITUS 8 0.0025
230 INJECTION SITE EXTRAVASATION 31 0.0025
231 HYPERSENSITIVITY 462 0.0025
232 GUILLAIN-BARRE SYNDROME 12 0.0025
233 RESPIRATORY RATE INCREASED 22 0.0025
234 NECK MASS 7 0.0025
235 THERAPY CHANGE 24 0.0024
236 RESPIRATORY DISORDER 73 0.0024
237 BREATH SOUNDS ABNORMAL 12 0.0024
238 HERNIA 47 0.0024
239 ORGANISING PNEUMONIA 12 0.0024
240 SUFFOCATION FEELING 6 0.0024
241 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
242 BILIARY COLIC 7 0.0024
243 INTERVERTEBRAL DISC PROTRUSION 52 0.0024
244 RETINAL ARTERY OCCLUSION 6 0.0024
245 KIDNEY INFECTION 46 0.0023
246 SINUSITIS 240 0.0023
247 NEOPLASM MALIGNANT 156 0.0023
248 BRONCHITIS 173 0.0023
249 STREPTOCOCCAL INFECTION 13 0.0023
250 FOOD ALLERGY 18 0.0023
251 PHYSICAL DECONDITIONING 6 0.0023
252 ASPHYXIA 19 0.0023
253 AMYOTROPHIC LATERAL SCLEROSIS 5 0.0023
254 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 15 0.0023
255 POSTMENOPAUSAL HAEMORRHAGE 6 0.0023
256 CEREBRAL DISORDER 17 0.0023
257 HYPERSENSITIVITY VASCULITIS 6 0.0023
258 GENERAL SYMPTOM 17 0.0023
259 MOUTH SWELLING 13 0.0023
260 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
261 ANEURYSM 11 0.0022
262 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 12 0.0022
263 SARS-COV-2 TEST POSITIVE 29 0.0022
264 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
265 RIB FRACTURE 45 0.0022
266 FOOD INTOLERANCE 8 0.0022
267 EAR DISORDER 10 0.0022
268 HERPES ZOSTER 125 0.0022
269 PNEUMONITIS 59 0.0022
270 CHILLS 254 0.0022
271 SUICIDAL BEHAVIOUR 9 0.0022
272 INJURY ASSOCIATED WITH DEVICE 44 0.0022
273 INCORRECT DISPOSAL OF PRODUCT 7 0.0022
274 PRODUCT LEAKAGE 12 0.0021
275 SKIN ABRASION 10 0.0021
276 SARCOIDOSIS 10 0.0021
277 WEIGHT FLUCTUATION 22 0.0021
278 LYME DISEASE 7 0.0021
279 CLAVICLE FRACTURE 8 0.0021
280 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
281 UPPER RESPIRATORY TRACT CONGESTION 6 0.0021
282 THERAPEUTIC PRODUCT INEFFECTIVE 8 0.0021
283 ABORTION 6 0.0021
284 PRODUCT ADMINISTRATION ERROR 41 0.0020
285 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
286 DEATH 1738 0.0020
287 DEAFNESS UNILATERAL 11 0.0020
288 RASH PRURITIC 108 0.0020
289 INTRACRANIAL ANEURYSM 8 0.0020
290 BRONCHIOLITIS 7 0.0020
291 LUMBAR VERTEBRAL FRACTURE 9 0.0020
292 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
293 COVID-19 PNEUMONIA 23 0.0019
294 CHOKING 38 0.0019
295 LARYNGEAL OEDEMA 12 0.0019
296 SOCIAL PROBLEM 8 0.0019
297 PULMONARY THROMBOSIS 21 0.0019
298 CUTANEOUS VASCULITIS 7 0.0019
299 DEAFNESS 50 0.0019
300 ORTHOPNOEA 6 0.0019
301 PNEUMONIA VIRAL 6 0.0019
302 THERAPEUTIC PRODUCT EFFECT DECREASED 84 0.0019
303 DRUG DOSE OMISSION BY DEVICE 146 0.0019
304 RASH VESICULAR 9 0.0019
305 RHINORRHOEA 120 0.0019
306 SINUS CONGESTION 25 0.0018
307 PARANASAL SINUS DISCOMFORT 7 0.0018
308 PULMONARY FIBROSIS 35 0.0018
309 LUNG INFILTRATION 16 0.0018
310 BLOOD PRESSURE ABNORMAL 36 0.0018
311 SKIN INJURY 6 0.0018
312 INJECTION SITE DISCOMFORT 19 0.0018
313 CHOLECYSTITIS INFECTIVE 5 0.0018
314 MENINGITIS ASEPTIC 8 0.0018
315 IRON DEFICIENCY 8 0.0018
316 OBESITY 28 0.0018
317 SKIN LACERATION 19 0.0017
318 IMMUNE SYSTEM DISORDER 23 0.0017
319 COLON CANCER 26 0.0017
320 BRAIN NEOPLASM 16 0.0017
321 VITAMIN B12 DEFICIENCY 7 0.0017
322 PAROSMIA 13 0.0017
323 ILL-DEFINED DISORDER 104 0.0017
324 DIVERTICULITIS 47 0.0017
325 LUNG TRANSPLANT 6 0.0017
326 HAEMOPTYSIS 47 0.0017
327 BODY HEIGHT DECREASED 18 0.0017
328 COMPRESSION FRACTURE 9 0.0017
329 CREPITATIONS 5 0.0017
330 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
331 MACULAR DEGENERATION 20 0.0017
332 PRODUCT DELIVERY MECHANISM ISSUE 9 0.0017
333 LOWER LIMB FRACTURE 32 0.0017
334 THROAT CANCER 7 0.0017
335 HYPERPYREXIA 7 0.0017
336 MONOCYTE COUNT INCREASED 6 0.0017
337 CRANIOCEREBRAL INJURY 5 0.0017
338 SKIN MASS 11 0.0016
339 TERMINAL STATE 11 0.0016
340 BLINDNESS 67 0.0016
341 FOOT FRACTURE 31 0.0016
342 THROAT IRRITATION 73 0.0016
343 SENSITIVE SKIN 12 0.0016
344 CARDIAC MURMUR 14 0.0016
345 PYREXIA 559 0.0016
346 ANKLE FRACTURE 25 0.0016
347 BACTERIAL INFECTION 30 0.0016
348 ANGIOPATHY 9 0.0016
349 INFLUENZA LIKE ILLNESS 132 0.0016
350 THROAT CLEARING 6 0.0016
351 SWELLING OF EYELID 10 0.0016
352 NEPHROLITHIASIS 73 0.0016
353 DEVICE ISSUE 142 0.0016
354 BREAST CANCER RECURRENT 5 0.0016
355 ABORTION SPONTANEOUS 63 0.0016
356 LYMPHADENOPATHY 55 0.0016
357 ASPIRATION 17 0.0016
358 HEADACHE 973 0.0016
359 SWELLING FACE 101 0.0015
360 IMMUNODEFICIENCY 23 0.0015
361 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
362 CONDITION AGGRAVATED 465 0.0015
363 IMMUNE THROMBOCYTOPENIA 7 0.0015
364 FACIAL PARALYSIS 13 0.0015
365 SLEEP APNOEA SYNDROME 29 0.0015
366 EYE PRURITUS 51 0.0015
367 BLOOD IRON DECREASED 18 0.0015
368 LIMB INJURY 41 0.0015
369 MUSCLE STRAIN 13 0.0015
370 OVERWEIGHT 8 0.0015
371 ORGAN FAILURE 6 0.0015
372 MYASTHENIA GRAVIS 12 0.0015
373 WRONG PRODUCT ADMINISTERED 10 0.0015
374 CARDIAC DISORDER 138 0.0015
375 PULMONARY OEDEMA 66 0.0015
376 HEART RATE INCREASED 146 0.0015
377 LIP SWELLING 49 0.0015
378 PERIPHERAL VENOUS DISEASE 6 0.0015
379 TRIGGER FINGER 6 0.0015
380 GOITRE 6 0.0015
381 PEMPHIGOID 11 0.0015
382 MALAISE 638 0.0015
383 INTESTINAL ISCHAEMIA 8 0.0015
384 EXPOSURE DURING PREGNANCY 90 0.0014
385 CEREBROVASCULAR ACCIDENT 243 0.0014
386 SKIN INFECTION 16 0.0014
387 INFUSION SITE ERYTHEMA 12 0.0014
388 ATRIOVENTRICULAR BLOCK 11 0.0014
389 CANDIDA INFECTION 24 0.0014
390 POLYNEUROPATHY 17 0.0014
391 NASOPHARYNGITIS 260 0.0014
392 SWOLLEN TONGUE 44 0.0014
393 MYALGIA 239 0.0014
394 DIABETES MELLITUS 107 0.0014
395 HYPERTENSION 297 0.0014
396 FEAR OF INJECTION 10 0.0014
397 FEELING COLD 39 0.0014
398 GALLBLADDER DISORDER 25 0.0014
399 HEREDITARY ANGIOEDEMA 15 0.0014
400 ARTHRALGIA 581 0.0014
401 DEVICE OPERATIONAL ISSUE 6 0.0014
402 MUSCULOSKELETAL DISCOMFORT 24 0.0014
403 MIGRAINE 133 0.0014
404 APPENDICITIS 13 0.0014
405 HIATUS HERNIA 18 0.0014
406 MONOPLEGIA 6 0.0014
407 PERIPHERAL SWELLING 211 0.0014
408 THROMBOSIS 110 0.0014
409 PHLEBITIS 7 0.0014
410 LUNG NEOPLASM MALIGNANT 56 0.0014
411 FRUSTRATION TOLERANCE DECREASED 11 0.0014
412 INFECTION 197 0.0014
413 CATARACT 81 0.0014
414 MASS 19 0.0014
415 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
416 MENINGITIS 9 0.0013
417 SPINAL FRACTURE 27 0.0013
418 PLEURISY 8 0.0013
419 INJECTION SITE PAIN 413 0.0013
420 POST-TRAUMATIC STRESS DISORDER 9 0.0013
421 RESPIRATORY DISTRESS 37 0.0013
422 BREAST MASS 9 0.0013
423 ACCIDENT 16 0.0013
424 DERMATITIS 28 0.0013
425 ANGIOEDEMA 59 0.0013
426 PRODUCT LABEL ISSUE 9 0.0013
427 ABDOMINAL HERNIA 6 0.0013
428 SENSATION OF FOREIGN BODY 11 0.0013
429 FEELING HOT 80 0.0013
430 INJECTION SITE URTICARIA 32 0.0013
431 HEAD DISCOMFORT 23 0.0013
432 UPPER RESPIRATORY TRACT INFECTION 60 0.0013
433 BRAIN INJURY 13 0.0013
434 GENERALISED OEDEMA 16 0.0013
435 BIPOLAR DISORDER 14 0.0013
436 CARPAL TUNNEL SYNDROME 18 0.0013
437 UMBILICAL HERNIA 6 0.0013
438 AGEUSIA 32 0.0013
439 HYPOACUSIS 55 0.0013
440 PRODUCT USE ISSUE 240 0.0013
441 BRAIN FOG 20 0.0013
442 BODY TEMPERATURE INCREASED 26 0.0013
443 FEELING ABNORMAL 305 0.0013
444 CELLULITIS 64 0.0013
445 PRODUCT PACKAGING ISSUE 12 0.0013
446 PRURITUS 482 0.0013
447 INJECTION SITE HAEMORRHAGE 100 0.0013
448 PURPURA 11 0.0012
449 ANAPHYLACTIC SHOCK 32 0.0012
450 PERIORBITAL SWELLING 7 0.0012
451 CARDIAC FLUTTER 8 0.0012
452 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
453 DERMATITIS CONTACT 14 0.0012
454 GASTROINTESTINAL INFECTION 11 0.0012
455 CARDIAC VALVE DISEASE 7 0.0012
456 INFLAMMATION 63 0.0012
457 RASH 532 0.0012
458 FALL 406 0.0012
459 SKIN ATROPHY 7 0.0012
460 ANAPHYLACTOID REACTION 5 0.0012
461 HIP FRACTURE 39 0.0012
462 CORONAVIRUS INFECTION 8 0.0012
463 INJECTION SITE RASH 37 0.0012
464 INJECTION SITE DISCOLOURATION 15 0.0012
465 DRUG INEFFECTIVE 1580 0.0012
466 ARTHRITIS 94 0.0012
467 NERVE COMPRESSION 11 0.0012
468 ATRIAL FIBRILLATION 116 0.0012
469 POSTOPERATIVE WOUND INFECTION 8 0.0012
470 AORTIC ANEURYSM 9 0.0012
471 DRY THROAT 12 0.0012
472 RESPIRATORY FAILURE 86 0.0012
473 IMPAIRED GASTRIC EMPTYING 16 0.0012
474 CARDIAC FAILURE CHRONIC 5 0.0012
475 HYPOKINESIA 17 0.0012
476 GAIT INABILITY 39 0.0012
477 MUSCULOSKELETAL CHEST PAIN 18 0.0012
478 CONCUSSION 9 0.0012
479 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
480 PELVIC FRACTURE 9 0.0012
481 NEURALGIA 28 0.0012
482 EYE INFECTION 13 0.0012
483 SPEECH DISORDER 60 0.0011
484 SENSITIVITY TO WEATHER CHANGE 6 0.0011
485 BLOOD TEST ABNORMAL 16 0.0011
486 ATELECTASIS 11 0.0011
487 SCRATCH 12 0.0011
488 COLD SWEAT 20 0.0011
489 CHEST PAIN 210 0.0011
490 PRODUCT DOSE OMISSION 74 0.0011
491 SLEEP DISORDER 80 0.0011
492 EAR INFECTION 30 0.0011
493 JOINT INJURY 24 0.0011
494 SENSORY DISTURBANCE 18 0.0011
495 PRODUCT SUPPLY ISSUE 8 0.0011
496 FACIAL PAIN 10 0.0011
497 NASAL DRYNESS 7 0.0011
498 FIBROMYALGIA 27 0.0011
499 MYOCARDIAL INFARCTION 192 0.0011
500 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
501 GASTROENTERITIS 16 0.0011
502 CARDIAC FAILURE CONGESTIVE 88 0.0011
503 TACHYCARDIA 97 0.0011
504 ORAL DISORDER 8 0.0011
505 SWELLING 102 0.0011
506 ANGINA PECTORIS 31 0.0011
507 HYPOXIA 38 0.0011
508 HEART RATE ABNORMAL 6 0.0011
509 BONE PAIN 63 0.0011
510 EAR DISCOMFORT 11 0.0011
511 ECZEMA 56 0.0011
512 OSTEOPOROSIS 44 0.0011
513 SKIN REACTION 15 0.0011
514 BLINDNESS UNILATERAL 15 0.0011
515 HYPOAESTHESIA ORAL 16 0.0011
516 GAIT DISTURBANCE 203 0.0011
517 TENDERNESS 11 0.0011
518 INTENTIONAL DOSE OMISSION 30 0.0011
519 EYE HAEMORRHAGE 14 0.0010
520 BREAST CANCER FEMALE 28 0.0010
521 BACK DISORDER 17 0.0010
522 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
523 NEOPLASM 12 0.0010
524 HERPES VIRUS INFECTION 6 0.0010
525 GLAUCOMA 20 0.0010
526 LIMB DISCOMFORT 32 0.0010
527 SYNCOPE 103 0.0010
528 ORAL HERPES 20 0.0010
529 FLUID RETENTION 52 0.0010
530 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
531 MENTAL DISORDER 44 0.0010
532 RENAL CYST 8 0.0010
533 INJECTION SITE REACTION 69 0.0010
534 COLITIS 38 0.0010
535 BLOOD PRESSURE INCREASED 153 0.0010
536 ANAL INCONTINENCE 9 0.0010
537 NODULE 13 0.0010
538 BURSITIS 12 0.0010
539 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
540 HAND FRACTURE 7 0.0010
541 ACUTE RESPIRATORY FAILURE 19 0.0010
542 ORAL CANDIDIASIS 13 0.0010
543 PRESYNCOPE 24 0.0010
544 CONTUSION 95 0.0010
545 DEVICE FAILURE 15 0.0010
546 MENISCUS INJURY 6 0.0010
547 CYSTITIS 31 0.0010
548 REBOUND EFFECT 11 0.0010
549 PIGMENTATION DISORDER 6 0.0010
550 CEREBRAL ISCHAEMIA 5 0.0010
551 DISCOMFORT 59 0.0010
552 PRODUCT PRESCRIBING ISSUE 21 0.0010
553 PULMONARY HYPERTENSION 20 0.0010
554 NERVOUSNESS 50 0.0010
555 ARTERIOSCLEROSIS 9 0.0010
556 BLOOD SODIUM DECREASED 18 0.0010
557 DERMATITIS ALLERGIC 12 0.0010
558 LEUKAEMIA 9 0.0010
559 PALPITATIONS 111 0.0009
560 CARDIAC FAILURE 76 0.0009
561 DIZZINESS 472 0.0009
562 MEMORY IMPAIRMENT 130 0.0009
563 JOINT DISLOCATION 10 0.0009
564 ARTHROPOD BITE 7 0.0009
565 URINARY TRACT INFECTION 160 0.0009
566 PULMONARY EMBOLISM 89 0.0009
567 NECK PAIN 52 0.0009
568 INTESTINAL OBSTRUCTION 35 0.0009
569 LACRIMATION INCREASED 28 0.0009
570 CHEILITIS 5 0.0009
571 PYELONEPHRITIS 8 0.0009
572 DRUG SPECIFIC ANTIBODY PRESENT 6 0.0009
573 PNEUMONIA ASPIRATION 23 0.0009
574 TENDON DISORDER 6 0.0009
575 MATERNAL EXPOSURE DURING PREGNANCY 82 0.0009
576 BACK PAIN 213 0.0009
577 VITREOUS FLOATERS 9 0.0009
578 BREAST CANCER 85 0.0009
579 VISUAL IMPAIRMENT 113 0.0009
580 LOCALISED INFECTION 22 0.0009
581 PERICARDIAL EFFUSION 21 0.0009
582 ADVERSE REACTION 12 0.0009
583 MOBILITY DECREASED 65 0.0009
584 FRACTURE 17 0.0009
585 SEPSIS 100 0.0009
586 MALIGNANT MELANOMA 12 0.0009
587 APHASIA 27 0.0009
588 GASTROINTESTINAL DISORDER 80 0.0009
589 EATING DISORDER 19 0.0009
590 OCULAR DISCOMFORT 10 0.0009
591 WEIGHT INCREASED 199 0.0009
592 TASTE DISORDER 18 0.0009
593 HEAD INJURY 28 0.0009
594 CHOLELITHIASIS 29 0.0009
595 SCAB 10 0.0009
596 EAR PAIN 17 0.0009
597 TEMPERATURE INTOLERANCE 9 0.0009
598 FATIGUE 679 0.0009
599 LYMPHOEDEMA 6 0.0009
600 MENTAL IMPAIRMENT 21 0.0009
601 INJECTION SITE MASS 32 0.0009
602 DISEASE RECURRENCE 41 0.0009
603 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
604 PAPULE 6 0.0009
605 EYE DISORDER 28 0.0009
606 EPILEPSY 26 0.0008
607 PAIN IN EXTREMITY 250 0.0008
608 LABORATORY TEST ABNORMAL 25 0.0008
609 ACCIDENTAL EXPOSURE TO PRODUCT 87 0.0008
610 THYROID DISORDER 13 0.0008
611 LOSS OF CONSCIOUSNESS 108 0.0008
612 BLOOD PRESSURE DECREASED 56 0.0008
613 RETINAL HAEMORRHAGE 6 0.0008
614 MOVEMENT DISORDER 27 0.0008
615 ISCHAEMIC STROKE 15 0.0008
616 PAIN 514 0.0008
617 RASH ERYTHEMATOUS 40 0.0008
618 TOOTH INFECTION 11 0.0008
619 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
620 PHARYNGITIS STREPTOCOCCAL 9 0.0008
621 GASTROENTERITIS VIRAL 15 0.0008
622 DERMATITIS BULLOUS 6 0.0008
623 OSTEOMYELITIS 15 0.0008
624 WOUND 23 0.0008
625 MAJOR DEPRESSION 6 0.0008
626 NEUROPATHY PERIPHERAL 78 0.0008
627 RENAL DISORDER 38 0.0008
628 NERVE INJURY 9 0.0008
629 LIGAMENT SPRAIN 8 0.0008
630 EYE SWELLING 30 0.0008
631 CYST 10 0.0008
632 HEPATIC STEATOSIS 15 0.0008
633 CORONARY ARTERY OCCLUSION 11 0.0008
634 OSTEOARTHRITIS 34 0.0008
635 NERVOUS SYSTEM DISORDER 25 0.0008
636 JOINT STIFFNESS 21 0.0008
637 THERAPY CESSATION 41 0.0008
638 GROIN PAIN 7 0.0008
639 PANCREATIC CARCINOMA 23 0.0008
640 GRIP STRENGTH DECREASED 7 0.0008
641 IMMUNOSUPPRESSION 7 0.0008
642 SKIN CANCER 17 0.0008
643 TINNITUS 36 0.0008
644 POST PROCEDURAL COMPLICATION 15 0.0008
645 INTENTIONAL PRODUCT MISUSE 68 0.0008
646 APHTHOUS ULCER 6 0.0008
647 FACE OEDEMA 13 0.0008
648 JOINT SWELLING 93 0.0008
649 VENTRICULAR EXTRASYSTOLES 8 0.0008
650 BURNING SENSATION 54 0.0008
651 ASTHENIA 289 0.0008
652 SPINAL PAIN 9 0.0008
653 ARRHYTHMIA 36 0.0008
654 GASTRITIS 20 0.0008
655 BACTERAEMIA 9 0.0008
656 NASAL DISCOMFORT 6 0.0008
657 PANCREATITIS 40 0.0008
658 CHOLECYSTITIS 9 0.0008
659 DYSSTASIA 22 0.0008
660 GENERAL PHYSICAL HEALTH DETERIORATION 87 0.0008
661 ERYTHEMA MULTIFORME 7 0.0007
662 FUNGAL INFECTION 25 0.0007
663 THYROID CANCER 9 0.0007
664 TYPE 2 DIABETES MELLITUS 25 0.0007
665 ROAD TRAFFIC ACCIDENT 31 0.0007
666 BACK INJURY 8 0.0007
667 TACHYPNOEA 10 0.0007
668 EXPOSURE VIA SKIN CONTACT 19 0.0007
669 SKIN LESION 20 0.0007
670 TREMOR 121 0.0007
671 PERIPHERAL COLDNESS 10 0.0007
672 INJECTION SITE NODULE 8 0.0007
673 CEREBRAL HAEMORRHAGE 26 0.0007
674 GOUT 13 0.0007
675 ACUTE CORONARY SYNDROME 6 0.0007
676 HEMIPLEGIA 6 0.0007
677 WEIGHT DECREASED 201 0.0007
678 ORAL DISCOMFORT 10 0.0007
679 PARAESTHESIA 113 0.0007
680 DYSPHAGIA 68 0.0007
681 STATUS EPILEPTICUS 8 0.0007
682 ERYTHEMA 145 0.0007
683 VITAMIN D DECREASED 6 0.0007
684 OEDEMA 38 0.0007
685 INFUSION SITE PAIN 9 0.0007
686 CEREBRAL INFARCTION 17 0.0007
687 SEIZURE 80 0.0007
688 SKIN SWELLING 6 0.0007
689 VERTIGO 42 0.0007
690 MUSCLE SPASMS 126 0.0007
691 RASH MACULAR 24 0.0007
692 BLOOD CALCIUM INCREASED 6 0.0007
693 GASTRIC ULCER 13 0.0007
694 HEART RATE DECREASED 24 0.0007
695 SPINAL OSTEOARTHRITIS 6 0.0007
696 INJECTION SITE BRUISING 54 0.0007
697 HYPOAESTHESIA 101 0.0007
698 PLEURAL EFFUSION 41 0.0007
699 INJECTION SITE PRURITUS 45 0.0007
700 MULTIPLE FRACTURES 11 0.0007
701 FLUSHING 68 0.0007
702 MUSCULAR WEAKNESS 76 0.0007
703 MYOSITIS 6 0.0007
704 STAPHYLOCOCCAL INFECTION 22 0.0007
705 HEART RATE IRREGULAR 15 0.0007
706 HYPERSOMNIA 19 0.0007
707 DRY EYE 33 0.0007
708 RENAL PAIN 7 0.0007
709 RESTLESS LEGS SYNDROME 12 0.0007
710 C-REACTIVE PROTEIN INCREASED 24 0.0007
711 OSTEOPENIA 10 0.0007
712 PRODUCT AVAILABILITY ISSUE 15 0.0007
713 INJECTION SITE ERYTHEMA 81 0.0007
714 IRRITABLE BOWEL SYNDROME 14 0.0007
715 BOWEL MOVEMENT IRREGULARITY 5 0.0007
716 SKIN DISCOLOURATION 30 0.0007
717 INJECTION SITE SWELLING 50 0.0007
718 POOR QUALITY SLEEP 14 0.0006
719 TENDON RUPTURE 8 0.0006
720 FEMUR FRACTURE 20 0.0006
721 APNOEA 5 0.0006
722 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
723 FEEDING DISORDER 13 0.0006
724 EYE PAIN 36 0.0006
725 SPINAL DISORDER 6 0.0006
726 FOOT DEFORMITY 7 0.0006
727 SKIN DISORDER 21 0.0006
728 SCIATICA 10 0.0006
729 BLOOD GLUCOSE DECREASED 30 0.0006
730 BLOOD DISORDER 5 0.0006
731 HYPERTHYROIDISM 9 0.0006
732 DRUG ERUPTION 11 0.0006
733 NIGHT SWEATS 20 0.0006
734 SKIN ULCER 16 0.0006
735 MUSCLE TIGHTNESS 10 0.0006
736 RHEUMATOID ARTHRITIS 70 0.0006
737 DRY MOUTH 50 0.0006
738 BLOOD POTASSIUM INCREASED 10 0.0006
739 THERAPY INTERRUPTED 44 0.0006
740 OCULAR HYPERAEMIA 29 0.0006
741 DYSARTHRIA 23 0.0006
742 CARDIOMYOPATHY 9 0.0006
743 SKIN HAEMORRHAGE 9 0.0006
744 METASTASES TO LUNG 7 0.0006
745 BLADDER DISORDER 6 0.0006
746 EPISTAXIS 45 0.0006
747 HYPOTHYROIDISM 19 0.0006
748 SUBARACHNOID HAEMORRHAGE 6 0.0006
749 MOTOR DYSFUNCTION 6 0.0006
750 HYPOPHAGIA 15 0.0006
751 DEPRESSED MOOD 31 0.0006
752 INITIAL INSOMNIA 6 0.0006
753 SCAR 10 0.0006
754 LYMPHOMA 9 0.0006
755 INSOMNIA 155 0.0006
756 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
757 ABDOMINAL DISCOMFORT 97 0.0006
758 PANIC ATTACK 21 0.0006
759 ALOPECIA 112 0.0006
760 INCORRECT DOSE ADMINISTERED 130 0.0006
761 BLOOD POTASSIUM DECREASED 17 0.0006
762 COLITIS ULCERATIVE 25 0.0006
763 ANXIETY 159 0.0006
764 FEAR 15 0.0006
765 ABDOMINAL DISTENSION 58 0.0006
766 BLISTER 31 0.0006
767 PRODUCT DISPENSING ERROR 12 0.0006
768 WOUND INFECTION 6 0.0005
769 DEVICE USE ERROR 19 0.0005
770 ADVERSE DRUG REACTION 49 0.0005
771 ROTATOR CUFF SYNDROME 7 0.0005
772 DYSURIA 20 0.0005
773 BLOOD GLUCOSE ABNORMAL 10 0.0005
774 LIVER DISORDER 24 0.0005
775 BREAST CANCER STAGE I 5 0.0005
776 RASH PAPULAR 12 0.0005
777 INTESTINAL PERFORATION 6 0.0005
778 THERAPY NON-RESPONDER 24 0.0005
779 CARDIAC ARREST 44 0.0005
780 DERMATITIS ATOPIC 28 0.0005
781 SEPTIC SHOCK 23 0.0005
782 PRODUCT USE IN UNAPPROVED INDICATION 131 0.0005
783 INTERNAL HAEMORRHAGE 6 0.0005
784 MUSCULOSKELETAL STIFFNESS 46 0.0005
785 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
786 GASTRIC HAEMORRHAGE 6 0.0005
787 VOMITING 244 0.0005
788 HYPOTENSION 104 0.0005
789 OEDEMA PERIPHERAL 63 0.0005
790 ABDOMINAL PAIN 120 0.0005
791 ACUTE MYOCARDIAL INFARCTION 15 0.0005
792 PRURITUS GENERALISED 11 0.0005
793 BODY TEMPERATURE DECREASED 5 0.0005
794 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
795 HAEMORRHAGE 53 0.0005
796 PREMATURE DELIVERY 8 0.0005
797 HYPERLIPIDAEMIA 6 0.0005
798 ABDOMINAL PAIN UPPER 103 0.0005
799 HEPATIC CANCER 12 0.0005
800 BALANCE DISORDER 43 0.0005
801 TOOTHACHE 9 0.0005
802 DEPRESSION 113 0.0005
803 PAIN IN JAW 14 0.0005
804 PARALYSIS 7 0.0005
805 OFF LABEL USE 428 0.0005
806 LETHARGY 28 0.0005
807 MEDICATION ERROR 27 0.0005
808 THERAPEUTIC RESPONSE DECREASED 29 0.0005
809 CONFUSIONAL STATE 77 0.0005
810 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
811 HYPERHIDROSIS 61 0.0005
812 FEELING JITTERY 9 0.0005
813 HEMIPARESIS 8 0.0005
814 RESPIRATORY ARREST 13 0.0005
815 EYE IRRITATION 27 0.0005
816 BREAST PAIN 5 0.0005
817 ARTHROPATHY 26 0.0005
818 HOT FLUSH 35 0.0005
819 HAEMATOMA 12 0.0005
820 DEEP VEIN THROMBOSIS 30 0.0005
821 BLOOD PRESSURE FLUCTUATION 11 0.0005
822 SYRINGE ISSUE 8 0.0005
823 DISABILITY 9 0.0005
824 NAUSEA 360 0.0005
825 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
826 SOMNOLENCE 91 0.0005
827 BASAL CELL CARCINOMA 7 0.0004
828 THIRST 8 0.0004
829 DEVICE BREAKAGE 18 0.0004
830 BONE DISORDER 8 0.0004
831 DEVICE MECHANICAL ISSUE 6 0.0004
832 SUICIDAL IDEATION 40 0.0004
833 SKIN IRRITATION 20 0.0004
834 ABDOMINAL PAIN LOWER 11 0.0004
835 HAEMATEMESIS 11 0.0004
836 VISION BLURRED 59 0.0004
837 MOUTH ULCERATION 9 0.0004
838 DISTURBANCE IN ATTENTION 23 0.0004
839 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
840 TREATMENT NONCOMPLIANCE 23 0.0004
841 PERICARDITIS 7 0.0004
842 PROSTATE CANCER 33 0.0004
843 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
844 HAEMORRHOIDS 8 0.0004
845 PALLOR 11 0.0004
846 DECREASED APPETITE 93 0.0004
847 AMNESIA 26 0.0004
848 COMA 19 0.0004
849 DYSPEPSIA 39 0.0004
850 PHARYNGEAL OEDEMA 6 0.0004
851 DEVICE RELATED INFECTION 6 0.0004
852 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
853 MENINGIOMA 6 0.0004
854 RESTLESSNESS 14 0.0004
855 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
856 CYANOSIS 6 0.0004
857 ULCER 6 0.0004
858 HEPATIC CIRRHOSIS 7 0.0004
859 PHOTOPHOBIA 7 0.0004
860 RENAL FAILURE 49 0.0004
861 CHOLESTASIS 7 0.0004
862 COGNITIVE DISORDER 17 0.0004
863 PHOTOSENSITIVITY REACTION 6 0.0004
864 POLLAKIURIA 15 0.0004
865 ORAL PAIN 8 0.0004
866 PANCREATITIS ACUTE 8 0.0004
867 HOSPITALISATION 54 0.0004
868 INTERSTITIAL LUNG DISEASE 17 0.0004
869 RASH GENERALISED 9 0.0003
870 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
871 NO ADVERSE EVENT 62 0.0003
872 METASTASES TO LIVER 6 0.0003
873 PRODUCT PREPARATION ERROR 7 0.0003
874 INJECTION SITE WARMTH 7 0.0003
875 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
876 URINARY INCONTINENCE 10 0.0003
877 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
878 CRYING 12 0.0003
879 URINARY RETENTION 11 0.0003
880 DIARRHOEA 211 0.0003
881 MUSCULOSKELETAL PAIN 17 0.0003
882 PROCEDURAL PAIN 9 0.0003
883 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
884 DYSGEUSIA 24 0.0003
885 THINKING ABNORMAL 6 0.0003
886 BLOOD CHOLESTEROL INCREASED 15 0.0003
887 RENAL IMPAIRMENT 27 0.0003
888 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
889 ACNE 24 0.0003
890 GASTRIC CANCER 8 0.0003
891 CARDIOVASCULAR DISORDER 8 0.0003
892 ERUCTATION 6 0.0003
893 DIPLOPIA 8 0.0003
894 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
895 DEHYDRATION 41 0.0003
896 SKIN FISSURES 6 0.0003
897 IMPAIRED HEALING 10 0.0003
898 ADVERSE EVENT 28 0.0003
899 CHRONIC KIDNEY DISEASE 23 0.0003
900 COAGULOPATHY 5 0.0003
901 PREMATURE BABY 9 0.0003
902 FULL BLOOD COUNT DECREASED 6 0.0003
903 PAIN OF SKIN 8 0.0003
904 INTENTIONAL SELF-INJURY 6 0.0003
905 DRUG EFFECT DECREASED 16 0.0003
906 PRODUCT STORAGE ERROR 26 0.0003
907 HEPATIC ENZYME INCREASED 20 0.0003
908 ANAEMIA 55 0.0003
909 KNEE ARTHROPLASTY 6 0.0003
910 DRY SKIN 38 0.0003
911 SKIN EXFOLIATION 24 0.0003
912 HALLUCINATION, VISUAL 6 0.0003
913 RETCHING 6 0.0003
914 SURGERY 16 0.0003
915 MULTIPLE SCLEROSIS 13 0.0003
916 UNRESPONSIVE TO STIMULI 7 0.0003
917 PSORIATIC ARTHROPATHY 11 0.0003
918 INJURY 19 0.0003
919 STEVENS-JOHNSON SYNDROME 6 0.0003
920 FLATULENCE 15 0.0003
921 UNEVALUABLE EVENT 20 0.0003
922 CORONARY ARTERY DISEASE 8 0.0003
923 NIGHTMARE 9 0.0003
924 EMOTIONAL DISORDER 8 0.0003
925 DRUG INTOLERANCE 25 0.0003
926 DEVICE DIFFICULT TO USE 17 0.0003
927 MOOD ALTERED 7 0.0003
928 BLOOD GLUCOSE INCREASED 48 0.0003
929 DISORIENTATION 10 0.0003
930 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
931 HYPONATRAEMIA 14 0.0002
932 DYSKINESIA 10 0.0002
933 RED BLOOD CELL COUNT DECREASED 7 0.0002
934 OSTEONECROSIS 8 0.0002
935 EXPIRED PRODUCT ADMINISTERED 8 0.0002
936 BLADDER CANCER 14 0.0002
937 DISEASE PROGRESSION 28 0.0002
938 OESOPHAGEAL CARCINOMA 7 0.0002
939 HAEMATOCHEZIA 13 0.0002
940 HAEMOGLOBIN DECREASED 24 0.0002
941 HAEMATURIA 8 0.0002
942 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
943 PLASMA CELL MYELOMA 9 0.0002
944 DELIRIUM 8 0.0002
945 PSORIASIS 30 0.0002
946 INFUSION RELATED REACTION 15 0.0002
947 SKIN BURNING SENSATION 16 0.0002
948 FREQUENT BOWEL MOVEMENTS 6 0.0002
949 NEUTROPHIL COUNT DECREASED 9 0.0002
950 RHABDOMYOLYSIS 9 0.0002
951 THROMBOCYTOPENIA 24 0.0002
952 HEPATIC FUNCTION ABNORMAL 8 0.0002
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
954 HYPOGLYCAEMIA 10 0.0002
955 IRRITABILITY 12 0.0002
956 STOMATITIS 12 0.0002
957 EXTRA DOSE ADMINISTERED 8 0.0002
958 PLATELET COUNT DECREASED 21 0.0002
959 GASTROINTESTINAL HAEMORRHAGE 16 0.0002
960 AGITATION 14 0.0002
961 RENAL CANCER 9 0.0002
962 CONSTIPATION 40 0.0002
963 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
964 TREATMENT FAILURE 15 0.0002
965 GASTRIC DISORDER 6 0.0002
966 HALLUCINATION 13 0.0002
967 CARDIO-RESPIRATORY ARREST 7 0.0002
968 VAGINAL HAEMORRHAGE 7 0.0002
969 EMOTIONAL DISTRESS 19 0.0002
970 PRODUCT QUALITY ISSUE 21 0.0002
971 HYPOKALAEMIA 7 0.0002
972 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
973 LEUKOPENIA 7 0.0001
974 RECTAL HAEMORRHAGE 6 0.0001
975 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
976 SUICIDE ATTEMPT 7 0.0001
977 DRUG INTERACTION 18 0.0001
978 BRADYCARDIA 6 0.0001
979 UNDERDOSE 8 0.0001
980 ACUTE KIDNEY INJURY 15 0.0001
981 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
982 INTENTIONAL OVERDOSE 6 0.0001
983 DRUG ABUSE 7 0.0001
984 DRUG DEPENDENCE 13 0.0001
985 NEUTROPENIA 10 0.0001
986 DRUG DOSE OMISSION 11 0.0001
987 OVERDOSE 10 0.0000
988 TOXICITY TO VARIOUS AGENTS 6 0.0000